These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11161817)

  • 1. Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q).
    Lai F; Godley LA; Joslin J; Fernald AA; Liu J; Espinosa R; Zhao N; Pamintuan L; Till BG; Larson RA; Qian Z; Le Beau MM
    Genomics; 2001 Jan; 71(2):235-45. PubMed ID: 11161817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cDNA cloning and genomic structure of three genes localized to human chromosome band 5q31 encoding potential nuclear proteins.
    Lai F; Godley LA; Fernald AA; Orelli BJ; Pamintuan L; Zhao N; Le Beau MM
    Genomics; 2000 Nov; 70(1):123-30. PubMed ID: 11087669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human CDC23: cDNA cloning, mapping to 5q31, genomic structure, and evaluation as a candidate tumor suppressor gene in myeloid leukemias.
    Zhao N; Lai F; Fernald AA; Eisenbart JD; Espinosa R; Wang PW; Le Beau MM
    Genomics; 1998 Oct; 53(2):184-90. PubMed ID: 9790767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map.
    Zhao N; Stoffel A; Wang PW; Eisenbart JD; Espinosa R; Larson RA; Le Beau MM
    Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6948-53. PubMed ID: 9192672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletions of chromosome 5 in malignant myeloid disorders.
    Le Beau MM
    Cancer Surv; 1992; 15():143-59. PubMed ID: 1451109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases.
    Le Beau MM; Espinosa R; Neuman WL; Stock W; Roulston D; Larson RA; Keinanen M; Westbrook CA
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5484-8. PubMed ID: 8516290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cDNA cloning, expression pattern, genomic structure and chromosomal location of RAB6KIFL, a human kinesin-like gene.
    Lai F; Fernald AA; Zhao N; Le Beau MM
    Gene; 2000 May; 248(1-2):117-25. PubMed ID: 10806357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidate gene isolation and comparative analysis of a commonly deleted segment of 7q22 implicated in myeloid malignancies.
    Kratz CP; Emerling BM; Donovan S; Laig-Webster M; Taylor BR; Thompson P; Jensen S; Banerjee A; Bonifas J; Makalowski W; Green ED; Le Beau MM; Shannon KM
    Genomics; 2001 Oct; 77(3):171-80. PubMed ID: 11597142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refinement of the smallest commonly deleted segment of chromosome 20 in malignant myeloid diseases and development of a PAC-based physical and transcription map.
    Wang PW; Eisenbart JD; Espinosa R; Davis EM; Larson RA; Le Beau MM
    Genomics; 2000 Jul; 67(1):28-39. PubMed ID: 10945467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31.
    Hu Z; Gomes I; Horrigan SK; Kravarusic J; Mar B; Arbieva Z; Chyna B; Fulton N; Edassery S; Raza A; Westbrook CA
    Oncogene; 2001 Oct; 20(47):6946-54. PubMed ID: 11687974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics.
    Eisenmann KM; Dykema KJ; Matheson SF; Kent NF; DeWard AD; West RA; Tibes R; Furge KA; Alberts AS
    Oncogene; 2009 Oct; 28(39):3429-41. PubMed ID: 19597464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
    Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
    Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of KLHL3, a human homologue of the Drosophila kelch gene.
    Lai F; Orelli BJ; Till BG; Godley LA; Fernald AA; Pamintuan L; Le Beau MM
    Genomics; 2000 May; 66(1):65-75. PubMed ID: 10843806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders.
    Joslin JM; Fernald AA; Tennant TR; Davis EM; Kogan SC; Anastasi J; Crispino JD; Le Beau MM
    Blood; 2007 Jul; 110(2):719-26. PubMed ID: 17420284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary conservation of zebrafish linkage group 14 with frequently deleted regions of human chromosome 5 in myeloid malignancies.
    Liu TX; Zhou Y; Kanki JP; Deng M; Rhodes J; Yang HW; Sheng XM; Zon LI; Look AT
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6136-41. PubMed ID: 11983906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel genes mapping to the critical region of the 5q- syndrome.
    Boultwood J; Fidler C; Soularue P; Strickson AJ; Kostrzewa M; Jaju RJ; Cotter FE; Fairweather N; Monaco AP; Müller U; Lovett M; Jabs EW; Auffray C; Wainscoat JS
    Genomics; 1997 Oct; 45(1):88-96. PubMed ID: 9339364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval.
    Horrigan SK; Westbrook CA; Kim AH; Banerjee M; Stock W; Larson RA
    Blood; 1996 Oct; 88(7):2665-70. PubMed ID: 8839861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription mapping of the 5q- syndrome critical region: cloning of two novel genes and sequencing, expression, and mapping of a further six novel cDNAs.
    Boultwood J; Fidler C; Strickson AJ; Watkins F; Kostrzewa M; Jaju RJ; Müller U; Wainscoat JS
    Genomics; 2000 May; 66(1):26-34. PubMed ID: 10843801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eukaryotic translation termination factor gene (ETF1/eRF1) maps at D5S500 in a commonly deleted region of chromosome 5q31 in malignant myeloid diseases.
    Guenet L; Henry C; Toutain B; Dubourg C; Le Gall JY; David V; Le Treut A
    Cytogenet Cell Genet; 2000; 88(1-2):82-6. PubMed ID: 10773672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases.
    Le Beau MM; Espinosa R; Davis EM; Eisenbart JD; Larson RA; Green ED
    Blood; 1996 Sep; 88(6):1930-5. PubMed ID: 8822909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.